DeutschNewstral
Article
bizjournals.com on 2019-07-18 17:27
Temple spinout takes high-tech approach to supporting drug discovery
Related news
- After AI drug discovery pact with Genentech, Stanford spinout lines up $52M Series A roundbizjournals.com
- Temple gets $5M for endow drug discovery centerbizjournals.com
- FNovartis CEO: We need a different approach to drug discoveryfortune.com
Oxford spinout Machine Discovery raises £4.5M for AI-powered simulationtech.eu- Temple spinout HGE Health broadens audience for its telemedicine technologybizjournals.com
- UNC spinout G1 tests chemo protection drug in cancer patientsbizjournals.com
- UW spinout takes the legwork out of drug developmentbizjournals.com
- OHSU spinout raised $1.5M for cancer drug platformbizjournals.com
- Baxter begins hiring in Cambridge for planned drug spinoutbizjournals.com
- Boston drug spinout Akcea acquired in $500M dealbizjournals.com
Darrell Clarke not supporting Temple stadium yetmetro.us
Archaeologists make grisly discovery at ancient templeFox News- FSupporting a BJD common sense approachfarmweekly.com.au
- Temple spinout ExpressCells adds new investors to meet 'rapidly growing demand'bizjournals.com
- Lab notes: Temple spinout advances gene-editing HIV treatment; 3 firms make board appointmentsbizjournals.com
- GUsing AI for drug discovery…geektime.com
- Twist's Covid spinout aims to develop drug for 'all known variants' of diseasebizjournals.com
- Exclusive: NIH spinout raises millions to attack drug-resistant cancers with RNA. It has big plans.bizjournals.com
- Drug industry veteran Tony Coles takes top spot at Pfizer spinout Cerevelbizjournals.com
- Drug by Ironwood spinout Cyclerion fails mid-stage trial; company plans cost cutsbizjournals.com